Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx<sup>®</sup>) or vincristine
<p>Abstract</p> <p>Background</p> <p>Chemotherapy for glioblastoma (GBM) patients is compromised in part by poor perfusion in the tumor. The present study evaluates how treatment with liposomal formulation of irinotecan (Irinophore C™), and other liposomal anticancer dr...
Main Authors: | Waterhouse Dawn, Kozlowski Piotr, Yung Andrew, Anantha Malathi, Masin Dana, Strutt Dita, Verreault Maite, Bally Marcel B, Yapp Donald T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/124 |
Similar Items
-
Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil.
by: Jennifer I Hare, et al.
Published: (2013-01-01) -
Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.
by: Maite Verreault, et al.
Published: (2013-01-01) -
Pegylated Liposomal Doxorubicin (Caelyx<sup>®</sup>) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial
by: Silvia Dellapasqua, et al.
Published: (2021-12-01) -
The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
by: Lu Xie, et al.
Published: (2024-02-01) -
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
by: Matthias Fröhlich, et al.
Published: (2021-11-01)